loadpatents
name:-0.0090410709381104
name:-0.007843017578125
name:-0.0035979747772217
Wiltshire; Hugh Patent Filings

Wiltshire; Hugh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wiltshire; Hugh.The latest application filed is for "dosing regimen for sedation with cns 7056 (remimazolam)".

Company Profile
3.8.8
  • Wiltshire; Hugh - Digswell GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dosing Regimen For Sedation With Cns 7056 (remimazolam)
App 20200316088 - Wilhelm-Ogunbiyi; Karin ;   et al.
2020-10-08
Dosing regimen for sedation with CNS 7056 (remimazolam)
Grant 10,722,522 - Wilhelm-Ogunbiyi , et al.
2020-07-28
Dosing Regimen For Sedation With Cns 7056 (remimazolam)
App 20200171046 - Wilhelm-Ogunbiyi; Karin ;   et al.
2020-06-04
Dosing regimen for sedation with CNS 7056 (Remimazolam)
Grant 10,342,800 - Wilhelm-Ogunbiyi , et al. July 9, 2
2019-07-09
Dosing Regimen For Sedation With Cns 7056 (remimazolam)
App 20190111062 - Wilhelm-Ogunbiyi; Karin ;   et al.
2019-04-18
Dosing regimen for sedation with CNS 7056 (Remimazolam)
Grant 10,195,210 - Wilhelm-Ogunbiyi , et al. Fe
2019-02-05
Dosing Regimen For Sedation With Cns 7056 (remimazolam)
App 20180318316 - Wilhelm-Ogunbiyi; Karin ;   et al.
2018-11-08
Dosing regimen for sedation with CNS 7056 (remimazolam)
Grant 10,052,334 - Wilhelm-Ogunbiyi , et al. August 21, 2
2018-08-21
Dosing Regimen For Sedation With Cns 7056 (remimazolam)
App 20180042939 - WILHELM-OGUNBIYI; Karin ;   et al.
2018-02-15
Dosing regimen for sedation with CNS 7056 (remimazolam)
Grant 9,827,251 - Wilhelm-Ogunbiyi , et al. November 28, 2
2017-11-28
Dosing regimen for sedation with CNS 7056 (Remimazolam)
Grant 9,737,547 - Wilhelm-Ogunbiyi , et al. August 22, 2
2017-08-22
Dosing Regimen For Sedation With Cns 7056 (remimazolam)
App 20170112852 - WILHELM-OGUNBIYI; Karin ;   et al.
2017-04-27
Dosing regimen for sedation with CNS 7056 (Remimazolam)
Grant 9,561,236 - Wilhelm-Ogunbiyi , et al. February 7, 2
2017-02-07
Dosing Regimen For Sedation With Cns 7056 (remimazolam)
App 20140080815 - Wilhelm-Ogunbiyi; Karin ;   et al.
2014-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed